Next Article in Journal
A Novel Combination Treatment with Honokiol and Rapamycin Effectively Restricts c-Met-Induced Growth of Renal Cancer Cells, and also Inhibits the Expression of Tumor Cell PD-L1 Involved in Immune Escape
Previous Article in Journal
Mechanosensitive Piezo Channels in Cancer: Focus on altered Calcium Signaling in Cancer Cells and in Tumor Progression
Open AccessArticle

Epigenetic Silencing of miR-9 Promotes Migration and Invasion by EZH2 in Glioblastoma Cells

by 1,2,†, 1,2,†, 1,2,3, 1,2,3,4, 5,6,* and 1,2,3,4,*
1
Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404, Taiwan
2
Center for Molecular Medicine, China Medical University Hospital, Taichung 404, Taiwan
3
Drug Development Center, China Medical University, Taichung 404, Taiwan
4
Department of Biotechnology, Asia University, Taichung 413, Taiwan
5
School of Medicine, College of Medicine, China Medical University, Taichung 404, Taiwan
6
Department of Neurosurgery, China Medical University Hospital, Taichung 404, Taiwan
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Cancers 2020, 12(7), 1781; https://doi.org/10.3390/cancers12071781
Received: 17 June 2020 / Accepted: 1 July 2020 / Published: 3 July 2020
Glioblastoma (GBM) is the most common primary brain tumor in adults. Tumor invasion is the major reason for treatment failure and poor prognosis in GBM. Inhibiting migration and invasion has become an important therapeutic strategy for GBM treatment. Enhancer of zeste homolog 2 (EZH2) and C-X-C motif chemokine receptor 4 (CXCR4) have been determined to have important roles in the occurrence and development of tumors, but the specific relationship between EZH2 and CXCR4 expression in GBM is less well characterized. In this study, we report that EZH2 and CXCR4 were overexpressed in glioma patients. Furthermore, elevated EZH2 and CXCR4 were correlated with shorter disease-free survival. In three human GBM cell lines, EZH2 modulated the expression of miR-9, which directly targeted the oncogenic signaling of CXCR4 in GBM. The ectopic expression of miR-9 dramatically inhibited the migratory capacity of GBM cells in vitro. Taken together, our results indicate that miR-9, functioning as a tumor-suppressive miRNA in GBM, is suppressed through epigenetic silencing by EZH2. Thus, miR-9 may be an attractive target for therapeutic intervention in GBM. View Full-Text
Keywords: enhancer of zeste homolog 2; CXCR4; miR-9; glioblastoma; invasion enhancer of zeste homolog 2; CXCR4; miR-9; glioblastoma; invasion
Show Figures

Figure 1

MDPI and ACS Style

Chien, Y.-C.; Chen, J.-N.; Chen, Y.-H.; Chou, R.-H.; Lee, H.-C.; Yu, Y.-L. Epigenetic Silencing of miR-9 Promotes Migration and Invasion by EZH2 in Glioblastoma Cells. Cancers 2020, 12, 1781. https://doi.org/10.3390/cancers12071781

AMA Style

Chien Y-C, Chen J-N, Chen Y-H, Chou R-H, Lee H-C, Yu Y-L. Epigenetic Silencing of miR-9 Promotes Migration and Invasion by EZH2 in Glioblastoma Cells. Cancers. 2020; 12(7):1781. https://doi.org/10.3390/cancers12071781

Chicago/Turabian Style

Chien, Yi-Chung; Chen, Jia-Ni; Chen, Ya-Huey; Chou, Ruey-Hwang; Lee, Han-Chung; Yu, Yung-Luen. 2020. "Epigenetic Silencing of miR-9 Promotes Migration and Invasion by EZH2 in Glioblastoma Cells" Cancers 12, no. 7: 1781. https://doi.org/10.3390/cancers12071781

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop